These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 9876392

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
    Cawston TE, Curry VA, Summers CA, Clark IM, Riley GP, Life PF, Spaull JR, Goldring MB, Koshy PJ, Rowan AD, Shingleton WD.
    Arthritis Rheum; 1998 Oct; 41(10):1760-71. PubMed ID: 9778217
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Dkk-1 promotes angiogenic responses and cartilage matrix proteinase secretion in synovial fibroblasts from osteoarthritic joints.
    Weng LH, Ko JY, Wang CJ, Sun YC, Wang FS.
    Arthritis Rheum; 2012 Oct; 64(10):3267-77. PubMed ID: 22736200
    [Abstract] [Full Text] [Related]

  • 26. Mixtures of glucosamine and chondroitin sulfate reverse fibronectin fragment mediated damage to cartilage more effectively than either agent alone.
    Homandberg GA, Guo D, Ray LM, Ding L.
    Osteoarthritis Cartilage; 2006 Aug; 14(8):793-806. PubMed ID: 16581272
    [Abstract] [Full Text] [Related]

  • 27. High concentrations of fibronectin fragments cause short-term catabolic effects in cartilage tissue while lower concentrations cause continuous anabolic effects.
    Homandberg GA, Hui F.
    Arch Biochem Biophys; 1994 Jun; 311(2):213-8. PubMed ID: 8203883
    [Abstract] [Full Text] [Related]

  • 28. Telopeptides of type II collagen upregulate proteinases and damage cartilage but are less effective than highly active fibronectin fragments.
    Guo D, Ding L, Homandberg GA.
    Inflamm Res; 2009 Mar; 58(3):161-9. PubMed ID: 19190855
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Identification of fibronectin neoepitopes present in human osteoarthritic cartilage.
    Zack MD, Arner EC, Anglin CP, Alston JT, Malfait AM, Tortorella MD.
    Arthritis Rheum; 2006 Sep; 54(9):2912-22. PubMed ID: 16948117
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The role of cytokines in arthritic diseases: in vitro and in vivo measurements of cartilage degradation.
    Dingle JT, Page Thomas DP, Hazleman B.
    Int J Tissue React; 1987 Sep; 9(4):349-54. PubMed ID: 3497901
    [Abstract] [Full Text] [Related]

  • 33. Exposure of cartilage to a fibronectin fragment amplifies catabolic processes while also enhancing anabolic processes to limit damage.
    Homandberg GA, Wen C.
    J Orthop Res; 1998 Mar; 16(2):237-46. PubMed ID: 9621898
    [Abstract] [Full Text] [Related]

  • 34. Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients.
    Koskinen A, Vuolteenaho K, Nieminen R, Moilanen T, Moilanen E.
    Clin Exp Rheumatol; 2011 Mar; 29(1):57-64. PubMed ID: 21345293
    [Abstract] [Full Text] [Related]

  • 35. A single blunt impact on cartilage promotes fibronectin fragmentation and upregulates cartilage degrading stromelysin-1/matrix metalloproteinase-3 in a bovine ex vivo model.
    Ding L, Guo D, Homandberg GA, Buckwalter JA, Martin JA.
    J Orthop Res; 2014 Jun; 32(6):811-8. PubMed ID: 24610678
    [Abstract] [Full Text] [Related]

  • 36. Monocyte chemoattractant protein-4 (MCP-4)/CCL13 is highly expressed in cartilage from patients with rheumatoid arthritis.
    Iwamoto T, Okamoto H, Iikuni N, Takeuchi M, Toyama Y, Tomatsu T, Kamatani N, Momohara S.
    Rheumatology (Oxford); 2006 Apr; 45(4):421-4. PubMed ID: 16303818
    [Abstract] [Full Text] [Related]

  • 37. Enhancement of SPARC (osteonectin) synthesis in arthritic cartilage. Increased levels in synovial fluids from patients with rheumatoid arthritis and regulation by growth factors and cytokines in chondrocyte cultures.
    Nakamura S, Kamihagi K, Satakeda H, Katayama M, Pan H, Okamoto H, Noshiro M, Takahashi K, Yoshihara Y, Shimmei M, Okada Y, Kato Y.
    Arthritis Rheum; 1996 Apr; 39(4):539-51. PubMed ID: 8630101
    [Abstract] [Full Text] [Related]

  • 38. Susceptibility of normal and arthritic human articular cartilage to degradative stimuli.
    Ismaiel S, Atkins RM, Pearse MF, Dieppe PA, Elson CJ.
    Br J Rheumatol; 1992 Jun; 31(6):369-73. PubMed ID: 1596698
    [Abstract] [Full Text] [Related]

  • 39. Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage.
    Patel L, Sun W, Glasson SS, Morris EA, Flannery CR, Chockalingam PS.
    BMC Musculoskelet Disord; 2011 Jul 15; 12():164. PubMed ID: 21762512
    [Abstract] [Full Text] [Related]

  • 40. [Fibronectin in the synovium and synovial fluid in rheumatoid arthritis and in osteoarthritis].
    Suzuki H.
    Nihon Seikeigeka Gakkai Zasshi; 1994 Apr 15; 68(4):172-83. PubMed ID: 8189099
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.